News

Haemonetics Releases Q2 Fiscal 2026 Financial Results Insights

Haemonetics Releases Q2 Fiscal 2026 Financial Results Insights

Haemonetics Corporation Financial Results Overview

Haemonetics Corporation (NYSE: HAE) has recently announced that its financial results for the second quarter of fiscal year 2026 are now accessible online. This comes after the quarter concluded on September 27, 2025, and represents a significant period of growth and evaluation for the company.

Online Availability of Financial Release

Investors can find the comprehensive financial release and an accompanying supplemental presentation on the company's Investor Relations website. This is part of Haemonetics’ commitment to transparency and keeping its stakeholders informed about its financial health and operational milestones.

Conference Call Details

The Company has scheduled a conference call and webcast to engage with investors and analysts regarding the results. The event is set for 8:00 a.m. ET on November 6, 2025. This is an opportunity for participants to gain insights and seek clarifications regarding the financial results released.

How to Participate

To participate in the conference call and webcast, investors must register beforehand. Upon completing the registration process, attendees will receive dial-in details and a personalized PIN, ensuring a streamlined experience. It's suggested that participants join the call 10 minutes early to prepare.

Accessing the Webcast

A live webcast will be available, allowing investors to tune into the call from any location. This format facilitates broader participation, offering an accessible platform for individuals who may not be able to attend in person.

Replay Option for Investors

For those unable to attend the live conference, a replay will be made available starting at 11:00 a.m. ET on the same day. The recording will remain accessible for one year, ensuring that all interested parties can review the discussion at their convenience.

Additional Information Available

Alongside the financial results, Haemonetics will share several important materials related to the earnings call. This includes the Second Quarter Fiscal 2026 Earnings Release and a Supplemental Earnings Presentation, both vital for a thorough understanding of the company's performance during this period.

About Haemonetics Corporation

Haemonetics is a leading global medical technology company that focuses on enhancing the efficiency and quality of health care through innovative solutions. These solutions encompass advanced hospital technologies, plasma collection systems, and blood component collection products designed to meet critical medical needs.

Contact Information for Investors

Investors seeking more information can reach out to Olga Guyette, Vice President of Investor Relations, or David Trenk, Manager of Investor Relations, via phone or email. They are available to provide additional insights on the company's financial results and strategies moving forward.

Media Inquiries

For media-related questions, Josh Gitelson, the Senior Director of Global Communications, is the point of contact. He is prepared to address media inquiries and provide relevant updates regarding company operations, innovations, and market strategies.

Frequently Asked Questions

What were the key financial highlights for Q2 Fiscal 2026?

The financial highlights for Q2 reflect various growth metrics, which can be explored in detail on the company's Investor Relations website.

How can I access the webcast for the conference call?

You can register for and access the live webcast through the Haemonetics Investor Relations page where the event will be streamed.

Is there a way to replay the conference call after it has concluded?

A replay will be available starting at 11:00 a.m. ET on the day of the call and will remain accessible for one year.

Who should I contact for investor-related questions?

You can contact Olga Guyette or David Trenk through the provided contact information for any investor queries.

What does Haemonetics focus on?

Haemonetics specializes in medical technologies that enhance healthcare outcomes, particularly in blood management and plasma collection.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 423

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 376

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 355

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 253

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 313

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 342

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

FG Nexus Unveils Major $200 Million Stock Buyback Initiative

Updated Category News Views 141

FG Nexus Announces $200 Million Share Repurchase Program Today, FG Nexus Inc. (Nasdaq: FGNX, FGNXP) has revealed a robust initiative, aiming to repurchase up to $200 million of its own common stock. This program has been officially sanctioned by the company's Board of Directors and offers an open-ended framework for share buyback activities. Strategic Repurchase Approach...

Continue Reading
Innovative ETF Launch for Enhanced Market Stability

Updated Category News Views 162

New Era of ETF Investment Solutions WEBs Investments Inc., an innovator in volatility-managed investment solutions, in collaboration with Westwood Holdings Group, has recently unveiled a transformative series of exchange-traded funds (ETFs). This initiative aims to align closely with today's dynamic market conditions and cater to the evolving needs of investors....

Continue Reading
Exploring Jovi Greene's Emotional Journey in 'Pink Ponies'

Updated Category News Views 466

Jovi Greene Unveils New Single 'Pink Ponies' Rising country star Jovi Greene is making significant strides in the music industry with his latest single, 'Pink Ponies.' Following his successful debut with 'Two Tone Top,' this new release aims to inspire listeners by encouraging them to hold onto their dreams while cherishing their childhood memories. Jovi is excited to...

Continue Reading
Zoetis and Danone Forge Partnership to Transform Dairy Farming

Updated Category News Views 759

Innovation in Dairy Farming Through Strategic Collaboration In a significant move for sustainable agricultural practices, Zoetis and Danone have announced their collaborative efforts aimed at revolutionizing dairy farming through genetic advancements. This strategic partnership merges Danone's dedication to environmental care with Zoetis' cutting-edge expertise in animal...

Continue Reading
Exploring the Booming Market of Running Apps and Trends

Updated Category News Views 327

The Growing Demand for Running Apps The Running Apps Market is currently segmented by type, including iOS and Android platforms, as well as by application type, categorized between amateur and professional runners. The increasing awareness of health and fitness is significantly contributing to the sustenance and growth of this vibrant market. Market Size and Projections...

Continue Reading